How To Earn $500 A Month From Medtronic Stock Ahead Of Q1 Earnings
Medtronic plc (NYSE:MDT) to release Q1 earnings on Sept. 1. Analysts expect $1.39/share, revenue of $9.54B. Dividend yield at 3.16%. Stock closed at $91.23 on Friday.
Benzinga4 days agoMDT

TD Cowen Maintains Buy on Medtronic, Raises Price Target to $110
TD Cowen analyst Joshua Jennings maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $100 to $110.
Benzinga7 days agoMDT

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B revenue. Stock fell 2.2% to $89.97 on Aug. 27.
Benzinga7 days agoMDT

Medtronic: The CAS Catalyst Can Close A 27% Peer Discount
Medtronic (MDT) stock rated Buy: CAS growth upside, discounted valuation, 3.1% yield, and key guidance variables. Read here for more analysis.
SeekingAlpha13 days agoMDT

Medtronic announces cash dividend for second quarter of fiscal year 2027
The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 20, 2026, approved the company's cash dividend for the second quarter of fiscal year 2027 of $0.72 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in June 2026. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 49 consecutive years. The dividend is payable on October 16, 2026,
Yahoo15 days agoMDT

Electrosurgery Market to Grow from USD 8.60 Billion in 2026 to USD 11.59 Billion by 2031, at a CAGR of 6.2% – MarketsandMarkets™
Delray Beach, FL, Aug. 20, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global electrosurgery market to grow from USD 8.60 billion in 2026 to USD 11.59 billion by 2031, at a CAGR of 6.2% during the forecast period. Market growth is driven by the rising prevalence of chronic diseases, increasing surgical procedure volumes, growing adoption of minimally invasive surgeries, continuous technological advancements in electrosurgical systems, expanding healthcare infrastructure, and the inc
Yahoo15 days agoMDT
Medtronic: Riding On Next-Gen Tech Medical Devices
Medtronic (MDT) Buy rating: cardiovascular device leadership, FY2026 revenue +8.4% and FY2027 7% growth guide.
SeekingAlpha15 days agoMDT

Medtronic: Expecting Strong Revenue Growth In Fiscal Q1
Medtronic is reiterated as a Buy, with shares offering over 10% fundamental upside and attractive valuation metrics. Read more on MDT stock here.
SeekingAlpha15 days agoMDT

Bank of America makes bullish call on 77-year-old healthcare stock
The company is heading toward earnings with one growth engine still running hot, while Bank of America sees another potential catalyst building.
Yahoo15 days agoMDT
BTIG Reiterates Buy on Medtronic, Maintains $91 Price Target
BTIG analyst Ryan Zimmerman reiterates Medtronic (NYSE:MDT) with a Buy and maintains $91 price target.
Benzinga17 days agoMDT

Boston Scientific: A Deep Dive Into The Headwinds And Why I See A Recovery Ahead
Boston Scientific (BSX) stock: EP/WATCHMAN slowdown drives discount valuation. See why itâs a Buyânew launches, insider buying, cost savings.
SeekingAlpha21 days agoMDT

Medtronic (NYSE:MDT) Combines Dividend Quality with a Sustainable Yield
Medtronic (MDT) passes a quality dividend screen with a 7/10 rating, 3.35% yield, strong profitability, and a sustainable payout—though health and payout ratio merit caution.
ChartMill21 days agoMDT

Wall Street Bulls Look Optimistic About Medtronic (MDT): Should You Buy?
According to the average brokerage recommendation (ABR), one should invest in Medtronic (MDT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Yahoo22 days agoMDT

FitLife Brands Inc. (FTLF) Beats Q2 Earnings and Revenue Estimates
FitLife Brands (FTLF) delivered earnings and revenue surprises of +11.11% and +0.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo22 days agoMDT